PTPA and familial pancreatic carcinoma: To evaluate whether inhibition of PP2A affects the antitumor effect of FUT‐175 and phosphorylated GSK‐3β level, we examined cell viability, GSK‐3 activity and apoptotic signal in the pancreatic cancer cell lines treated by FUT‐175 with PP2A inhibitor.